Literature DB >> 13595659

An outbreak of aseptic meningitis with a rubella-like rash probably caused by ECHO virus type 9.

A BERGLUND, M BOTTIGER, T JOHNSSON, S E WESTERMARK.   

Abstract

Entities:  

Keywords:  MENINGITIS/microbiology; RUBELLA; VIRUS DISEASES

Mesh：

Year:  1958        PMID： 13595659     DOI： 10.1007/bf01243744

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  13 in total

1.  Studies of an epidemic of aseptic meningitis associated with Coxsackie and ECHO viruses. I. Virological observations.

Authors:  T JOHNSSON; B JONSSON; E LYCKE; B WICTORIN
Journal:  Arch Gesamte Virusforsch       Date:  1957

2.  Association of mouse pathogenic strain of Echo virus type 9 with aseptic meningitis.

Authors:  D M MCLEAN; J L MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1957-04

3.  ECHO virus type 9 as the agent responsible for an important outbreak of aseptic meningitis in Belgium.

Authors:  E NIHOUL; L QUERSIN-THIRY; A WEYNANTS
Journal:  Am J Hyg       Date:  1957-07

4.  [The incidence of echo viruses in Switzerland].

Authors:  U KRECH
Journal:  Schweiz Med Wochenschr       Date:  1957-05-11

5.  Echo virus type 9 (new member of Coxsackie group type A?) as a cause of epidemic meningitis.

Authors:  L QUERSIN-THIRY; E NIHOUL; F DEKKING
Journal:  Science       Date:  1957-04-19       Impact factor: 47.728

6.  A study of the association of ECHO viruses to aseptic meningitis.

Authors:  G VON ZEIPEL; A SVEDMYR
Journal:  Arch Gesamte Virusforsch       Date:  1957

7.  Isolation of ECHO virus type 9 from cerebrospinal fluids.

Authors:  A GODTFREDSEN; H VON MAGNUS
Journal:  Dan Med Bull       Date:  1957-12

8.  An unusual illness in young children associated with an enteric virus.

Authors:  M CRAWFORD; A D MACRAE; J N O'REILLY
Journal:  Arch Dis Child       Date:  1956-06       Impact factor: 3.791

9.  Cytopathogenic agents isolated from patients during an unusual epidemic exanthem.

Authors:  F A NEVA; J F ENDERS
Journal:  J Immunol       Date:  1954-04       Impact factor: 5.422

10.  Complement fixation with the three types of poliomyelitis viruses propagated in tissue culture.

Authors:  A SVEDMYR; J F ENDERS; A HOLLOWAY
Journal:  Am J Hyg       Date:  1953-01
View more
  9 in total

1.  Properties of epidemic strains of ECHO type 9 virus and observations on the nature of human infection.

Authors:  R WIGAND; A B SABIN
Journal:  Arch Gesamte Virusforsch       Date:  1962

2.  [Epidemiology of ECHO virus infections].

Authors:  A GIOVANARDI; F BERGAMINI
Journal:  Arch Gesamte Virusforsch       Date:  1963

3.  A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.

Authors:  H J EGGERS; A B SABIN
Journal:  Arch Gesamte Virusforsch       Date:  1961

4.  [On the problem of the neuropathogenicity of enteroviruses. Experimental studies on the neuropathogenicity of various strains of ECHO-9 virus].

Authors:  H PETTE; G MAASS; L VALENCIANO; K MANNWEILER
Journal:  Arch Gesamte Virusforsch       Date:  1961

5.  [Tissue culture experiments with material from exanthema infectiosum variabile].

Authors:  K HERZBERG; G MAY; K LAPPE
Journal:  Klin Wochenschr       Date:  1960-04-15

6.  New Rashes for Old.

Authors: 
Journal:  Br Med J       Date:  1960-06-11

7.  Polioviruses, coxsackieviruses, and echoviruses comparison of the genomes by RNA hybridization.

Authors:  N A Young
Journal:  J Virol       Date:  1973-06       Impact factor: 5.103

8.  [The complement fixation reaction with coxsackie and ECHO virus antigens].

Authors:  E A Polzin; W A Schmidt; R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1969

9.  Observations on the cytological diagnosis of an infectious erythema.

Authors:  C MUSETEANU; D VISINESCU
Journal:  J Clin Pathol       Date:  1963-05       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.